Bio-Connect

Anti-DDIT3 Antibody [JM10-31]

ET1703-05
HUABIO
ApplicationsFlow Cytometry, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetDDIT3
100 ul
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    HUABIO
  • Product Name
    Anti-DDIT3 Antibody [JM10-31]
  • Delivery Days Customer
    7
  • Applications
    Flow Cytometry, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Applications Supplier
    WB,IHC-P,FC
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    JM10-31
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID1649
  • Target name
    DDIT3
  • Target description
    DNA damage inducible transcript 3
  • Target synonyms
    AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153, DNA damage-inducible transcript 3 protein, C/EBP zeta, CCAAT/enhancer-binding protein homologous protein, alternative DDIT3 protein, c/EBP-homologous protein 10, growth arrest and DNA damage-inducible protein GADD153
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP35638
  • Protein Name
    DNA damage-inducible transcript 3 protein
  • Scientific Description
    DNA damage-inducible transcript 3, also known as C/EBP homologous protein (CHOP), is a pro-apoptotic transcription factor that is encoded by the DDIT3 gene. It is a member of the CCAAT/enhancer-binding protein (C/EBP) family of DNA-binding transcription factors. The protein functions as a dominant-negative inhibitor by forming heterodimers with other C/EBP members, preventing their DNA binding activity. The protein is implicated in adipogenesis and erythropoiesis and has an important role in the cells stress response. The regulation of CHOP expression plays an important role in metabolic diseases and in some cancers through its function in mediating apoptosis. The regulation of CHOP expression could be a potential approach to affecting cancer cells through the induction of apoptosis. In the intestinal epithelium, CHOP has been demonstrated to be downregulated under inflammatory conditions (in inflammatory bowel diseases and experimental models of colitis). In this context, CHOP seems to rather regulate the cell cycle than apoptotic processes. Mutations or fusions of CHOP (e.g. with FUS to form FUS-CHOP) can cause Myxoid liposarcoma.
  • Reactivity
    Human, Mouse, Rat
  • Reactivity Supplier
    Human,Mouse,Rat
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    41116161